Cargando…
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy
Aromatase inhibitors (AIs), such as anastrozole, are established in the treatment of hormone-dependent breast cancer. However, ∼20% of patients with hormone receptor-positive breast tumors treated with anastrozole do not respond and it remains impossible to accurately predict sensitivity. Since poly...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570232/ https://www.ncbi.nlm.nih.gov/pubmed/23408108 http://dx.doi.org/10.3892/etm.2012.878 |